Broad melanocortin receptor agonist that produces skin darkening (MC1R), increased libido (MC3R/MC4R), and appetite suppression (MC4R) simultaneously. The original 'Barbie drug' — a multi-effect peptide that tans without UV, enhances sexual function, and reduces appetite. Less selective than PT-141 but offers the tanning benefit.
Melanotan II activates all five melanocortin receptor subtypes with varying affinity. This broad activation profile produces the combined tanning, libido, and appetite effects — but also means more potential side effects than selective compounds like PT-141.
MT-II uses a loading protocol to build pigmentation, followed by maintenance dosing to sustain it. Start very low — nausea is common and dose-dependent. Tanning effects develop gradually over 1–3 weeks.
Melanotan II was developed at the University of Arizona in the 1990s by researchers seeking a tanning agent that could protect fair-skinned individuals from UV radiation and skin cancer. The unexpected sexual arousal side effects were significant enough to spawn an entire research program.
The compound activates all five melanocortin receptor subtypes (MC1R–MC5R), explaining its multi-effect profile. The tanning effect (MC1R) was the intended target; the sexual enhancement (MC3R/MC4R) and appetite suppression (MC4R) were serendipitous discoveries.
Safety concerns center on the potential for melanocyte overstimulation — existing moles can darken, new moles can appear, and there is a theoretical (unproven but concerning) link to melanoma acceleration. Dermatological screening before and during use is the standard recommendation.
| Compound | Selectivity | Tanning | Libido | Appetite |
|---|---|---|---|---|
| Melanotan II | Pan-MC (1-5R) | ✓ Strong | ✓ Strong | ↓ Suppressed |
| PT-141 | MC3R/MC4R | ✗ None | ✓ Strong | Minimal |
| Melanotan I (Afamelanotide) | MC1R Selective | ✓ Strong | ✗ Minimal | ✗ None |
Melanotan II's side effect profile is manageable with proper protocol adherence. Baseline blood work before starting and periodic monitoring during use is essential.
Melanotan II does three things at once: tans your skin, enhances libido, and suppresses appetite. For some users, that's the perfect profile. For others, PT-141 (libido only) or Melanotan I (tanning only) offer cleaner, more targeted alternatives. The main safety concern is melanocyte overstimulation — mole darkening, new mole formation, and the theoretical melanoma risk. Dermatological screening before starting is non-negotiable. Start at 0.1mg to manage nausea, dose in the evening, and monitor your skin closely. If you just want the libido effect without tanning, use PT-141 instead.
Our free Protocol Guide includes the complete hormonal section — MT-II loading protocol, PT-141 comparison, and safety monitoring.